In STEMI, hyperglycemia tied to larger myocardial area-at-risk

March 8, 2014
In STEMI, hyperglycemia tied to larger myocardial area-at-risk

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), hyperglycemia is associated with larger area-at-risk and infarct size, and the effect of exenatide treatment is independent of glucose levels, according to a study published online Feb. 28 in Diabetes.

Jacob Lønborg, M.D., Ph.D., from Copenhagen University Hospital in Denmark, and colleagues examined the correlation between and infarct size, myocardial salvage, and area-at-risk in a cohort of 210 patients with STEMI. Participants were randomized to receive intravenous exenatide or placebo before , and the interaction between exenatide and hyperglycemia was assessed.

The researchers found that larger area-at-risk and infarct size were seen for patients with hyperglycemia versus those with normoglycemia, but no difference was seen between the groups in the salvage index and infarct size after adjustment for area-at-risk. For patients with hyperglycemia and those with normoglycemia, exenatide treatment correlated with increased salvage index.

"Thus, we conclude that the association between hyperglycemia upon admission and infarct size in STEMI patients is a consequence of a larger myocardial area-at-risk but not on a reduction in myocardial salvage. Also, cardioprotection by exenatide treatment is independent of admission ," the authors write. "Hyperglycemia does not influence the effect of the reperfusion treatment but rather represents a surrogate marker for the severity of myocardium at risk and injury."

One author disclosed being a shareholder in CellAegis; several authors disclosed financial ties to Eli Lilly.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

AMI up with stress-induced hyperglycemia after hip fx

July 15, 2013

(HealthDay)—For patients after hip fracture, stress-induced hyperglycemia is associated with an increased risk of acute myocardial infarction (AMI), according to a study published online July 11 in Diabetes Care.

Results of the CHILL-MI trial presented

October 31, 2013

A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of ...

Hyperglycemia may increase myocardial infarction mortality

November 6, 2013

(HealthDay)—Hyperglycemia is common among patients presenting with myocardial infarction and is associated with a higher risk of death, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

White blood cell count predicts infarct size in STEMI

December 19, 2013

(HealthDay)—For patients with anterior wall ST-segment elevated myocardial infarction (STEMI), elevated white blood cell count (WBCc) on presentation is associated with increased infarct size, according to a study published ...

Recommended for you

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

'Crosstalk' gives clues to diabetes

June 15, 2015

Sometimes, listening in on a conversation can tell you a lot. For Mark Huising, an assistant professor in the Department of Neurobiology, Physiology and Behavior at the UC Davis College of Biological Sciences, that crosstalk ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.